The largest database of trusted experimental protocols

Tgfb2

Manufactured by R&D Systems
Sourced in United States

Tgfb2 is a recombinant human protein that belongs to the transforming growth factor beta (TGF-beta) family. TGF-beta proteins are involved in the regulation of cellular processes, including cell growth, differentiation, and immune function. Tgfb2 specifically plays a role in the modulation of these cellular activities.

Automatically generated - may contain errors

3 protocols using tgfb2

1

Left Ventricular Explant Angiogenesis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Left ventricular explant culture was performed and adapted as previously described.8 (link) Hearts were isolated in cold PBS from E12.5 BmxCreER;R26fsGFP embryos which were tamoxifen induced at E11.5. After removal of the atrium, the right ventricle, and septum of the heart, the left ventricle was rinsed with PBS twice to remove circulating cells, placed on the surface of pre-casted basement membrane matrix (200 μl/well) (BD Matrigel, growth factor reduced) in Nunc 4-well plates, and then sandwiched by adding an additional 150 μl of Matrigel. The Matrigel was prepared by addition of an equal volume of Endothelial Cell Growth Basal Medium (R&D, Cat# CCM029) with or without a testing growth factor, including Vegf120 (R&D, Cat# 494-VE-025) and Tgfb2 (R&D, Cat# 7346-B2–005). The final concentration of Vegf120 growth factor in the cultures was 10 ng/ml and Tgfb2 growth factor in the cultures was 2 ng/ml or 10 ng/ml, respectively. Heart explants were cultured at 37°C for up to nine days. The features of angiogenesis including transmural migration, sprouting, and endothelial networking were examined and photographed.
+ Open protocol
+ Expand
2

Astrocyte Survival Assay with Cytokines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Acutely isolated astrocytes were plated at 2,000 cells/well in poly-d-lysine-coated (PDL) 24-well plates in base media with 0.5 µg/ml aphidicolin (Sigma A0781). Unless otherwise noted, candidate cytokines were individually added at the following concentrations: 5 ng/ml HbEGF (Peprotech); 100 ng/ml IGF2 (R&D Systems); 100 ng/ml CXCL12 (R&D Systems); 50 ng/ml BDNF (Peprotech); 10 ng/ml NT3 (Peprotech); 10 ng/ml FGF1, FGF2, FGF8, and FGF9 (Peprotech); 100 ng/ml BMP2, BMP4, BMP5, BMP6, BMP7, BMP10, BMP15, GDF3, and GDF5 (R&D Systems); 250 ng/ml Activin A (R&D Systems); 100 ng/ml Nodal (R&D Systems); 100 ng/ml TGFB2 (R&D Systems). Survival was assayed at 3DIV using a Live/Dead kit in which calcein AM stains live cells green and ethidium homodimer stains dead cells red (Life Technologies L3224). At least 3 independent experiments were conducted for each condition. For each experiment, 3 non-overlapping 20x fields per well were quantified in triplicate wells. Significance determined using one-way ANOVA with Dunnett correction.
+ Open protocol
+ Expand
3

TGF-β Modulation of α-SMA in MIO-M1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effects of TGF-b1 or TGF-b2 administration on the expression of a-SMA in MIO-M1 cells seeded onto PAGs of varying elastic moduli (2, 4, 12, 26, and 92 kPa) were studied.
The coverslips without PAGs that underwent the entire crosslinking and type I collagen-coating procedure were used as a control group. MIO-M1 cells were seeded onto the PAGs (5 3 10 4 /cm 2 ) in 6-well plates and allowed to adhere in stock medium containing 10% FBS for 24 hours at 378C with 5% CO 2 . Afterwards, MIO-M1 cells were treated with recombinant TGF-b1 or TGF-b2 (10 ng/mL 6 ; R&D Systems, Minneapolis, MN, USA) or PBS, which was used as a negative control. After 48 hours of incubation in a cell culture incubator, the MIO-M1 cells were collected for immunocytologic analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!